TEV Protease, His
| $50.00 | |
| Z03030-1K | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| $50.00 | |
| Z03030-1K | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
| Source | E. coli |
| Purity | > 95% by SDS-PAGE analyses. |
| Biological Activity | 10 IU/μl. |
| Unit Definition | One unit of TEV protease cleaves > 85% of 3 μg of control substrate in 1 hour at pH 8.0 at 30°C. |
| Molecular Weight | 28.4 kDa, observed by reducing SDS-PAGE. |
| Formulation | Sterile liquid solution contains 50mM Tris, 5mM DTT, 50% glycerol, pH7.5. |
| Storage & Stability | Recombinant Tobacco Etch Virus Protease (rTEV) remains stable for 1 year at -20°C from date of receipt. Please avoid freeze-thaw cycles. |
»
Lane 1: 2 μg of TEV Protease, His, non-reducing (NR)
Lane 2: 2 μg of TEV Protease, His, reducing (R)
> 95% as analyzed by SDS-PAGE
»
The fusion protein (20 μg) was incubated with varying enzyme doses (2U, 3U, 4U, 5U) in a 30°C water bath for 1 hour. »
| Synonyms | rTEV, TEV, P1 protease |
| Target Background | Tobacco Etch Virus Protease is a highly site-specific cysteine protease that is found in the Tobacco Etch Virus (TEV). The optimum recognition site for this enzyme is the sequence Glu-Asn-Leu-Tyr-Phe-Gln- (Gly/Ser) [ENLYFQ(G/S)] and cleavage occurs between the Gln and Gly/Ser residues, The most commonly used sequence is ENLYFQG. The protease is used to cleave affinity tags from fusion proteins. The optimal temperature for cleavage is 30°C; also it can be used at temperature as low as 4°C. It is recommended that the cleavage for each fusion protein be optimized by varying the amount of recombinant viral TEV protease, reaction time, or incubation temperature. It can be removed by Ni2+ affinity resin. Recombinant Tobacco Etch Virus Protease (rTEV) contains 231 amino acids with N-terminal His tagged.A fully biologically active molecule, rTEV has a molecular mass of 28.4 kDa and is obtained by proprietary chromatographic techniques at GenScript. |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.